期刊文献+

老年慢性心力衰竭患者心功能与血清甲状腺激素、血浆N末端原脑利钠肽的变化及对预后的影响 被引量:16

Study on changes in blood levels of thyroid hormones and N-terminal pro-brain natriuretic peptide and its influence on prognosis of elderly patients with congestive heart failure
下载PDF
导出
摘要 目的:探讨老年慢性心力衰竭患者心功能与血清甲状腺激素、血浆N末端原脑利钠肽的变化及对预后的影响。方法:选择80例老年慢性心力衰竭患者,根据心功能分级分为2组,分别测定血浆N末端原脑利钠肽(NT-proBNP)、血清三碘甲状腺氨酸(T3)、甲状腺素(T4)、游离三碘甲状腺氨酸(FT3)、游离甲状腺素(FT4)及促甲状腺素(TSH)水平。比较2组间甲状腺激素水平变化及NT-proB-NP的变化。结果:心功能Ⅳ级患者与心功能Ⅱ级、Ⅲ级患者比较,T3和FT3明显降低,差异具有统计学意义,P<0.05。NT-proBNP随着心功能不全加重而升高,两组相比差异具有统计学意义,P<0.05。而T4、FT4、TSH均无明显变化,差异无统计学意义,P>0.05。结论:甲状腺激素、NT-proB-NP与老年慢性心力衰竭患者的心功能严重程度有关,影响预后。 Objective. To study the changes in blood levels of thyroid hormones and N-terminal pro-brain natriuretic peptide and its influence on prognosis of elderly patients with congestive heart failure. Methods. A total of 80 elderly patients with congestive heart failure were divided into two groups according to the grade of function of heart. Blood levels of NT-proBNP,T3,T4,FT3,FT4 and TSH were measured in these patients. Results. The blood levels of T3 and FT3 were significantly decreased in elderly patients with grade 1V congestive heart failure compared with those of patients with grade Ⅲ-If congestive heart failure (P〈0.05). Blood level of NT-proBNP increased with the severity of chronic heart failure (P〈 0.05). But no significant difference in T4, FT4 and TSH were observed (P〈0.05). Conclusion. Blood levels of thyroid hormones and NT-proBNP were related wtih severity of cardiac dysfunction in elderly pa- tients with congestive heart failure, it affects prognosis.
作者 余信强
出处 《海南医学院学报》 CAS 2013年第7期898-900,共3页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210698)~~
关键词 慢性心力衰竭 甲状腺激素 血浆N末端原脑利钠肽 Congestive heart failure Thyroid hormones NT-proBNP
  • 相关文献

参考文献10

二级参考文献113

共引文献3789

同被引文献145

  • 1任明霞,张茂洪.慢性心力衰竭患者血浆超敏C反应蛋白和N末端脑钠肽原水平变化及意义[J].湖北医药学院学报,2011,30(5):529-530. 被引量:16
  • 2饶大勇,许贤德.慢性心力衰竭患者血清总胆红素水平对预后判断的临床观察[J].中国心血管杂志,2006,11(5):378-379. 被引量:7
  • 3杨福珍,张苗,徐章,李愉.冠心病患者血清甲状腺激素变化及临床意义[J].昆明医学院学报,1996,17(4):39-40. 被引量:1
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 6Clcland JGF, Khand A, Clark A. The heart failure epidemic: exactly how big is it[J]. Eur Heart J,2001,22 (8) :623 -626.
  • 7Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metab- olism in the normal and failing heart[ J]. Physiol Rev,2005,85 (3) : 1093.
  • 8Neubauer S. The failing heart an engine out of fuel[ J]. N Engl J Med, 2007,356 : 1140.
  • 9Peacock WF 4th, Holland R, Gyannathy R, et al. Observation unit treatment of heart failure with nesiritide :results from the proaction trial [J]. J Em erg Med,2005,29(3) :243 -252.
  • 10Kozdag G,Ertas G,Kilic T. Elevated level of highsensitivity C-rcactive protein is important in determining prognosis in chronic heart failure[J].{H}MEDICAL SCIENCE MONITOR,2010,(03):CR156-CR161.

引证文献16

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部